American Head & Neck Society
Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.
HOSPITAL MEMORIAL S. JOSE
56 Rua Tenente Antônio João
Graças
Recife
Pernambuco
52011-130
Brazil
Phone: +55819.9971-4448
Email: [email protected]
Web Site:
Endocrine Surgery, Head and Neck Surgeon
Head and Neck Surgeon
Houston Methodist Hospital
6550 Fannin Street
Smith Tower, Suite 1723
Houston
TX
77030
United States
Phone: 713-441-1368
Email: [email protected]
Web Site: https://www.houstonmethodist.org/doctor/nadia-mohyuddin/
Endocrine Surgery, Head and Neck Surgeon
Undergraduate & Medical School: University of Missouri-Kansas City Combined BA/MD Program 1997-2003 (Degrees: Biology & Chemistry, Honors with Distinction)
Internship: General Surgery, University of Illinois-Chicago 2003-2004
Residency: Otolaryngology/Head & Neck Surgery, University of Illinois-Chicago 2004-2008
Fellowship: Head and Neck Surgical Oncology & Microvascular Reconstruction, Medical University of South Carolina 2008-2009
Assistant Professor, Bobby R. Alford Department of Otolaryngology/Head and Neck Surgery, Baylor College of Medicine 2009-2018
Faculty, Houston Methodist Hospital 2018-present
Wayne State University
4201 Saint Antoine Street
UHC Suite 5-E
Detroit
Michigan
48201
United States
Phone: 313-577-0804
Email:
Web Site:
Head and Neck Surgeon, Reconstructive Head & Neck Surgery
Resident in Otolaryngology- Head and Neck Surgery
Wayne State University / Karmanos Cancer Institute
University of Maryland School of Medicine – Dept of Otolaryngology
16 S. Eutaw Street
Suite, 500
Baltimore
MD
21201
United States
Phone: 410-328-3197
Email:
Web Site:
Kyle Hatten, MD is the Director of Robotic Surgery in the Department of Otorhinolaryngology – Head & Neck Surgery and the University of Maryland. He received his training at the University of Pennsylvania in head and neck oncology, microvascular reconstruction, and robotic surgery.
Dr. Hatten’s practice focuses on the care of pediatric and adult patients with malignant and benign tumors of the head and neck including cancers of the oral cavity, pharynx, and larynx; tumors of the paranasal sinuses; tumors of the salivary glands; and cutaneous malignancies including melanoma of the head and neck. Dr. Hatten is trained to perform open and endoscopic approaches for treatment of tumors of the skull base as well as complex reconstruction of head and neck defects using microvascular free flap techniques.
University of Southern California – Keck Medical Center
1450 San Pablo Street
Los Angeles
California
90033
United States
Phone: 323-442-5790
Email:
Web Site: https://keck.usc.edu/otolaryngology/faculty/Mark-Swanson/
Endocrine Surgery, Head and Neck Research, Head and Neck Surgeon, Reconstructive Head & Neck Surgery
Mark Swanson, MD is a fellowship trained head and neck surgeon. After completing medical school at the Ohio State University, he entered a residency in Otolaryngology at University of Southern California. He continued his training with a fellowship in cancer and reconstructive surgery at the University of Miami, and returned to USC to join the faculty at Keck Medical Center. His expertise is in treatment of benign and malignant tumors of the mouth, throat, salivary glands, neck, and thyroid gland. He utilizes advanced robotic, organ preservation, and microvascular reconstructive techniques to maximize quality of life after treatment.
Dr. Swanson works in a multi-disciplinary team including surgeons, radiation oncologists, medical oncologists, and speech/swallow therapists to provide complete care for head and neck diseases.
In addition to treating patients, Dr. Swanson has a research interest in oncologic and quality of life outcomes in head and neck cancers. He focuses on swallowing and voice outcomes after cancer treatments, and is working to provide optimal cancer outcomes while preserving unaffected tissues.
Head and neck squamous cell cancer related trials
Bertelsen C, Swanson MS, et al. Contrast-Enhanced Ultrasound with Perflubutane for Sentinel Lymph Node Mapping in Cutaneous Melanoma: A Pilot Study. Laryngoscope – In Press
Swanson MS, Low G, Sinha UK, Kokot N. Transoral surgery vs intensity-modulated radiotherapy for early supraglottic cancer: a systematic review. Current opinion in otolaryngology & head and neck surgery. April 2017, 25 (2):133-141. [PMID 28106658]
Swanson MS, Kokot N, Sinha UK. The Role of HPV in Head and Neck Cancer Stem Cell Formation and Tumorigenesis. Cancers. 2016; Feb 19;8(2): 24. [PMID 2907349]
Ouyoung, L.M., M.S. Swanson, B.C. Villegas, et al., ABCLOVE: Voice therapy outcomes for patients with head and neck cancer. Head Neck, 2016. 38 Suppl 1: p. E1810-3. [PMID 26689974]
Swanson MS, Hudson R, Bhandari N, Sinha UK, Maceri DR, Kokot N. Use of Octreotide for the Management of Chyle Fistula Following Neck Dissection. JAMA Otolaryngol Head Neck Surg. 2015 Aug;141(8):723-7. [PMID 26135979]
Swanson MS, Sinha UK. Rationale for combined blockade of PD-1 and CTLA-4 in Advanced Head and Neck Squamous Cell Cancer – Review of Current Data. Oral Oncology. 2015 Jan; 51(1):12-15. [PMID 25459157]
Swanson MS, Brown, TN. Laryngotracheal giant cell tumor: case report and literature review. Case reports in Clinical Pathology. 2015; 2(2). http://dx.doi.org/10.5430/crcp.v2n2p12 [DOI: 10.5430/crcp.v2n2p12]
Swanson MS, Sinha UK. Diagnosis and Management of Merkel Cell Carcinoma of the Head and Neck: Current Trends and Controversies. Cancers. 2014; 6(3):1256-1266. [PMID 24978433]
Radhakrishnan V, Swanson MS, Sinha UK. Monoclonal Antibodies as Treatment Modalities in Head and Neck Cancers. AIMS Medical Science, 2015, 2(4): 347-359. [DOI: 10.3934/medsci.2015.4.347]